Vaccines, Blood & Biologics
-
HEMACORD (HPC, cord blood)
STN: BL 125397/0
Proper Name: HEMACORD (HPC, Cord Blood)
Trade Name: Manufacture: New York Blood Center, Inc
Indication: For use in unrelated donor hematopoietic progenitor cell transplantation procedures in conjunction with an appropriate preparative regimen for hematopoietic and immunologic reconstitution in patients with disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment.
-
Supporting Documents
April 3, 2013 Approval Letter, Hemacord HPC Cord Blood
a change in the non-proprietary name to HPC, Cord Blood for the final package insert with instructions.November 10, 2011 Approval Letter - Hemacord
Indicated for use in unrelated donor hematopoietic progenitor cell transplantation procedures in conjunction with an appropriate preparative regimen for hematopoietic and immunologic reconstitution in patients with disorders.Summary Basis for Regulatory Action, November 10, 2011 - Hemacord (PDF - 199KB)Approval History, Letters, Reviews and Related Documents - Hemacord
-
-
-
